Cargando…
Identification and Characterization of a Novel Single Domain Antibody Against Ebola Virus
Ebola virus (EBOV) belongs to the Filoviridae family and causes severe illnesses such as hemorrhagic fever with a high mortality rate up to 90%. Now two antibody drugs termed Inmazeb and Ebanga have been approved for treating EBOV infection. However, clinical studies have demonstrated that the morta...
Autores principales: | Wang, Rui, Zhang, Haiwei, Peng, Cheng, Shi, Jian, Zhang, Huajun, Gong, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502631/ https://www.ncbi.nlm.nih.gov/pubmed/34632543 http://dx.doi.org/10.1007/s12250-021-00454-z |
Ejemplares similares
-
Selection, characterization, and thermal stabilization of llama single domain antibodies towards Ebola virus glycoprotein
por: Liu, Jinny L., et al.
Publicado: (2017) -
Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylactics
por: Zhao, Shaojuan, et al.
Publicado: (2021) -
Potent neutralizing monoclonal antibodies against Ebola virus infection
por: Zhang, Qi, et al.
Publicado: (2016) -
Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus
por: Cui, Qinghua, et al.
Publicado: (2018) -
Selection and identification of single-domain antibody against Peste des Petits Ruminants virus
por: Liu, Dan, et al.
Publicado: (2021)